Florence Sejourne
Florence Séjourné is the Chief Executive Officer of Da Volterra, a late-stage biotech company developing innovative products to prevent the life-threatening consequences of microbiome disruption. Florence Séjourné graduated from MINES ParisTech in 1994 with a specialization in biotechnology, and from the University of Illinois in Chicago with a Master's degree in Bioengineering and Pharmaceutical Sciences in 1996. She started her career managing the biotechnology department of Eurasanté, one of the first French bioincubators, and was in charge of the valorization of regional research and of company creation. Prior to joining Da Volterra in 2008 as President and CEO, Florence co-founded Genfit (Euronext GNFT), a leading biotech company in the field of metabolic and inflammatory diseases, in 1999. As Director of Operations, Business Development and Alliances, and member of the Executive Board, she has greatly contributed to the development of the company, including its successful IPO in 2006. Florence Séjourné brings to Da Volterra the experience of successful entrepreneurial ventures, her ability to build and lead a highly professional R&D organization, to raise private and public funds, and to structure and negotiate agreements with pharmaceutical and biotechnology companies in a highly competitive international environment.
